Adjunct Instructor at Tsinghua Medical School @ (March 2016 - Present)
Chief Medical Officer @ (November 2021 - Present)
Adjunct Professor @ (December 2016 - December 2022)
Founder, Chairman and CEO @ DeltaMed Co. Ltd 德泰迈医药科技有限公司 (May 2018 - January 2022)
Partner @ Yuanming Capital (February 2015 - January 2022)
CEO and Founder @ Hangzhou Tigermed-IntelliPV (November 2013 - April 2018)
Chief Medical Officer @ (January 2015 - January 2017)
Senior Director at Global Safety @ (July 2008 - November 2012)
Medical Director at GPVE @ (July 2007 - July 2008)
Director of Global Pharmacovigilance @ (April 2006 - July 2007)
Safety Physician @ (May 2000 - June 2005)
Medical Safety Scientist @ (May 1998 - May 2000)
Howe 李浩 Education
美国北卡罗来纳大学教堂山分校
Post-doctoral Fellow (Molecular Biology and Biochemistry)
1991-1993
Peking Union Medical College
Master of Medicine (Pathology)
1986-1991
华中科技大学同济医学院
MD (Clinical Medicine)
1981-1986
Howe 李浩 Summary
Howe 李浩, based in Shanghai, China, is currently a Acting CMO at Himalaya Therapeutics. Howe 李浩 brings experience from previous roles at 丽维泰生物医药(上海)有限公司 (LIVIUS Shanghai Pharmaceutical LTD), Tsinghua University, Pharmaron and Shanghai Jiao Tong University School of Medicine. Howe 李浩 holds a 1991 - 1993 Post-doctoral Fellow in Molecular Biology and Biochemistry @ 美国北卡罗来纳大学教堂山分校. Howe 李浩 has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Howe 李浩?
Find contact details for 700 million professionals.